Yuen‐Li Chung

6.7k total citations · 2 hit papers
66 papers, 4.6k citations indexed

About

Yuen‐Li Chung is a scholar working on Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yuen‐Li Chung has authored 66 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 19 papers in Cancer Research and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yuen‐Li Chung's work include Cancer, Hypoxia, and Metabolism (17 papers), Advanced MRI Techniques and Applications (16 papers) and Metabolomics and Mass Spectrometry Studies (11 papers). Yuen‐Li Chung is often cited by papers focused on Cancer, Hypoxia, and Metabolism (17 papers), Advanced MRI Techniques and Applications (16 papers) and Metabolomics and Mass Spectrometry Studies (11 papers). Yuen‐Li Chung collaborates with scholars based in United Kingdom, United States and Canada. Yuen‐Li Chung's co-authors include John R. Griffiths, Thomas Porstmann, Almut Schulze, B Griffiths, Mary Wu, Sally J. Leevers, Cláudio R. Santos, Megan Cully, Martin O. Leach and Helen Troy and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Circulation Research.

In The Last Decade

Yuen‐Li Chung

65 papers receiving 4.5k citations

Hit Papers

SREBP Activity Is Regulated by mTORC1 and Contributes to ... 2005 2026 2012 2019 2008 2005 250 500 750 1000

Peers

Yuen‐Li Chung
László G. Boros United States
Ru Wei United States
Daniel A. Tennant United Kingdom
Yang Xu China
Camilo Rojas United States
Ilana Nissim United States
Raphael A. Nemenoff United States
Anne Le United States
Natalya N. Pavlova United States
László G. Boros United States
Yuen‐Li Chung
Citations per year, relative to Yuen‐Li Chung Yuen‐Li Chung (= 1×) peers László G. Boros

Countries citing papers authored by Yuen‐Li Chung

Since Specialization
Citations

This map shows the geographic impact of Yuen‐Li Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuen‐Li Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuen‐Li Chung more than expected).

Fields of papers citing papers by Yuen‐Li Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuen‐Li Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuen‐Li Chung. The network helps show where Yuen‐Li Chung may publish in the future.

Co-authorship network of co-authors of Yuen‐Li Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Yuen‐Li Chung. A scholar is included among the top collaborators of Yuen‐Li Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuen‐Li Chung. Yuen‐Li Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andrejeva, Gabriela, Sharon Gowan, Gigin Lin, et al.. (2019). De novo phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagy. Autophagy. 16(6). 1044–1060. 76 indexed citations
2.
Beloueche‐Babari, Mounia, Markela Koniordou, Harold G. Parkes, et al.. (2017). MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy. Cancer Research. 77(21). 5913–5924. 105 indexed citations
3.
Chung, Yuen‐Li. (2017). Magnetic Resonance Spectroscopy (MRS)-Based Methods for Examining Cancer Metabolism in Response to Oncogenic Kinase Drug Treatment. Methods in molecular biology. 1636. 393–404. 3 indexed citations
4.
Chung, Yuen‐Li, et al.. (2013). Molecular and Metabolic Consequences Following E6 Transfection in an Isogenic Ovarian Cell Line (A2780) Pair. Cellular Physiology and Biochemistry. 32(5). 1460–1472. 5 indexed citations
5.
Hill, Deborah K., Yann Jamin, Matthew Orton, et al.. (2013). 1H NMR and hyperpolarized 13C NMR assays of pyruvate–lactate: a comparative study. NMR in Biomedicine. 26(10). 1321–1325. 21 indexed citations
6.
Beloueche‐Babari, Mounia, Helen Troy, Robert te Poele, et al.. (2011). Histone Deacetylase Inhibition Increases Levels of Choline Kinase α and Phosphocholine Facilitating Noninvasive Imaging in Human Cancers. Cancer Research. 72(4). 990–1000. 23 indexed citations
7.
Troy, Helen, Yuen‐Li Chung, Paul M.J. McSheehy, et al.. (2011). Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas. BMC Cancer. 11(1). 198–198. 24 indexed citations
8.
Chung, Yuen‐Li & John R. Griffiths. (2008). Using Metabolomics to Monitor Anticancer Drugs. PubMed. 55–78. 19 indexed citations
9.
Willingham, Mark C., John Sinclair, Amna Butt, et al.. (2006). A parallel proteomic and metabolomic analysis of the hydrogen peroxide‐ and Sty1p‐dependent stress response in Schizosaccharomyces pombe . PROTEOMICS. 6(9). 2772–2796. 60 indexed citations
10.
Workman, Paul, Eric O. Aboagye, Yuen‐Li Chung, et al.. (2006). Minimally Invasive Pharmacokinetic and Pharmacodynamic Technologies in Hypothesis-Testing Clinical Trials of Innovative Therapies. JNCI Journal of the National Cancer Institute. 98(9). 580–598. 134 indexed citations
11.
Isaacs, Jennifer S., Yun Jin Jung, David R. Mole, et al.. (2005). HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability. Cancer Cell. 8(2). 143–153. 732 indexed citations breakdown →
12.
Porstmann, Thomas, B Griffiths, Yuen‐Li Chung, et al.. (2005). PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene. 24(43). 6465–6481. 368 indexed citations
13.
Mayr, Manuel, Richard Siow, Yuen‐Li Chung, et al.. (2004). Combined proteomic and metabolomic analysis of vascular smooth muscle cells: role of PKCdelta. Atherosclerosis. 174(1). 3 indexed citations
14.
Mayr, Manuel, Ursula Mayr, Yuen‐Li Chung, et al.. (2004). Vascular proteomics: Linking proteomic and metabolomic changes. PROTEOMICS. 4(12). 3751–3761. 56 indexed citations
15.
Somerville, Robert A., et al.. (2004). Microdissection: A method developed to investigate mechanisms involved in transmissible spongiform encephalopathy pathogenesis. BMC Infectious Diseases. 4(1). 8–8. 11 indexed citations
16.
Chung, Yuen‐Li, Helen Troy, Ian Judson, et al.. (2003). Pharmacokinetic measurements of a 5FU pro-drug, capecitabine, in bladder tumours over-expressing thymidine phosphorylase. Clinical Cancer Research. 9. 2 indexed citations
17.
Lundberg, Ingrid E. & Yuen‐Li Chung. (2000). Treatment and investigation of idiopathic inflammatory myopathies. Lara D. Veeken. 39(1). 7–17. 33 indexed citations
18.
Chung, Yuen‐Li, Steven Williams, James Hope, & Jimmy D. Bell. (1999). Brain bioenergetics in murine models of scrapie using in vivo 31P magnetic resonance spectroscopy. Neuroreport. 10(9). 1899–1901. 3 indexed citations
19.
Chung, Yuen‐Li, et al.. (1996). Metabolic Changes Associated with Vacuolation in Murine Models of Scrapie usingIn Vitro1H-NMR Spectroscopy. NMR in Biomedicine. 9(8). 359–363. 2 indexed citations
20.
Chung, Yuen‐Li, Steven Williams, John S. Beech, et al.. (1995). MRI Assessment of the Blood-Brain Barrier in a Hamster Model of Scrapie. PubMed. 4(2). 203–207. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026